Julia V. Johnson — Endo Lab

other 2008

Evaluation of extended and continuous use oral contraceptives

Therapeutics and clinical risk management ·doi:10.2147/tcrm.s2143

Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the a…

article 1992

A prospective, randomized trial comparing two different intrauterine insemination regimens in controlled ovarian hyperstimulation cycles

·doi:10.1016/s0015-0282(16)54845-6

ObjectiveTo compare a single periovulatory intrauterine insemination (IUI) with a regimen employing two IUIs, one before ovulation and one after ovulation, in patients undergoing controlled ovarian hyperstimulation with human menopausal gon…

article 1992

Ethiodol oil contrast medium inhibits macrophage phagocytosis and adherence by altering membrane electronegativity and microviscosity

·doi:10.1016/s0015-0282(16)55254-6

ObjectiveTo examine the effect of Ethiodol oil-soluble contrast medium and Sinografin aqueous-soluble contrast medium on macrophage function. After the observation that Ethiodol alters macrophage phagocytosis and adherence, we sought to det…

article 1992

Method for the transportation of peritoneal macrophages

·doi:10.1016/s0015-0282(16)55578-2

This report outlines a method of PF transport that preserves the viability and activation level of peritoneal macrophages. Collection of macrophages in this manner will allow transport of PF from multiple centers for evaluation of macrophag…

article 1991

c-myc protooncogene polypeptide expression in endometriosis

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(91)90580-k

The c-myc protooncogene and its polypeptide product are important regulators of cell proliferation and differentiation, and ovarian steroids are believed to stimulate growth of various uterine cell types through altered expression of the c-…